Appearing as a significant breakthrough in the fight against obesity, this medication is generating considerable attention . This treatment combines effects of two established GLP-1 receptor agonists, liraglutide, and an unique glucose-dependent peptide component. Early clinical results have demonstrated substantial weight decrease in people with